双特异性的临床试验
总计1193个结果
-
Pfizer主动,不招人多发性骨髓瘤 | 难治性多发性骨髓瘤 | 骨髓瘤 | 复发性多发性骨髓瘤 | 埃拉那他单抗 | PF-06863135 | BCMA | 双特异性 | 双特异性抗体 | BCMA-CD3双特异性 | 磁铁MM-8中国
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)招聘中
-
Vanderbilt UniversityNational Cancer Institute (NCI)终止
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
University of ChicagoNational Cancer Institute (NCI)完全的
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)撤销未明确的儿童实体瘤,具体方案 | 未明确的成人实体瘤,特定方案
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
University of East AngliaUniversity of Hertfordshire; London South Bank University; Health Education England (East of England) 和其他合作者完全的
-
National Taipei University of Nursing and Health...Cheng-Hsin General Hospital完全的
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey撤销未明确的儿童实体瘤,具体方案 | 未明确的成人实体瘤,特定方案 | 造血/淋巴癌美国
-
Universitat Jaume IUniversidad de Zaragoza; University of Seville; Universidad Rey Juan Carlos完全的
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)终止未明确的儿童实体瘤,具体方案 | 疲劳 | 未明确的成人实体瘤,特定方案美国
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)完全的
-
Jonsson Comprehensive Cancer CenterNovartis Pharmaceuticals完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)完全的
-
University of Wisconsin, MadisonTyrogenex完全的
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)终止
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)终止
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Ohio State University Comprehensive Cancer Center完全的
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)完全的
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)完全的
-
Mayo ClinicNational Cancer Institute (NCI)撤销